Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 157,531 | 170,438 | 183,233 | 84,602 | 92,570 |
| TOTAL | $161,068 | $174,404 | $186,359 | $84,865 | $92,914 |
| Non-Current Assets | |||||
| PPE Net | 2,913 | 789 | 689 | 694 | 651 |
| Other Non-Current Assets | 15,269 | 3,182 | 3,370 | 3,877 | 2,833 |
| TOTAL | $18,182 | $3,971 | $4,059 | $4,571 | $3,484 |
| Total Assets | $179,250 | $178,375 | $190,418 | $89,436 | $96,398 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,037 | 1,457 | 3,193 | 1,800 | 1,021 |
| Accrued Expenses | 8,765 | 5,574 | 3,456 | 2,890 | 3,586 |
| Other current liabilities | N/A | N/A | N/A | 20 | N/A |
| TOTAL | $11,874 | $7,775 | $7,370 | $5,409 | $5,284 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14,589 | 1,297 | 1,492 | 237,781 | 142,977 |
| TOTAL | $14,589 | $1,297 | $1,492 | $237,781 | $142,977 |
| Total Liabilities | $26,463 | $9,072 | $8,862 | $243,190 | $148,261 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,654 | 27,579 | 27,568 | 27,568 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -252,895 | -235,026 | -221,268 | -153,756 | -51,865 |
| TOTAL | $152,787 | $169,303 | $181,556 | $-153,754 | $-51,863 |
| Total Liabilities And Equity | $179,250 | $178,375 | $190,418 | $89,436 | $96,398 |